PMC:7565665 / 64567-64838
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T426 | 178-180 | Body_part | denotes | CS | http://purl.org/sig/ont/fma/fma284995 |
| T427 | 260-265 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T465 | 102-104 | Disease | denotes | CF | http://purl.obolibrary.org/obo/MONDO_0009061 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T762 | 260-265 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
| T763 | 267-269 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T17243 | 147-157 | Chemical | denotes | cysteamine | http://purl.obolibrary.org/obo/CHEBI_17141|http://purl.obolibrary.org/obo/CHEBI_58029 |
| T137 | 178-180 | Chemical | denotes | CS | http://purl.obolibrary.org/obo/CHEBI_73462 |
| T8987 | 228-236 | Chemical | denotes | ceramide | http://purl.obolibrary.org/obo/CHEBI_17761|http://purl.obolibrary.org/obo/CHEBI_52639 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1610 | 253-259 | Species | denotes | murine | Tax:10090 |
| 1614 | 40-50 | Chemical | denotes | cysteamine | MESH:D003543 |
| 1615 | 147-157 | Chemical | denotes | cysteamine | MESH:D003543 |
| 1616 | 228-236 | Chemical | denotes | ceramide | MESH:D002518 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T865 | 189-198 | http://purl.obolibrary.org/obo/GO_0061724 | denotes | lipophagy |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T334 | 0-271 | Sentence | denotes | Similarly, our recent studies validated cysteamine’s extensive repertoire of protective mechanisms in CF, and demonstrated for the first time that cysteamine was able to control CS-induced lipophagy impairment and the resulting ceramide accumulation in murine lungs [22]. |